Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Can Amphastar (AMPH) Keep the Earnings Surprise Streak Alive?
01:32pm, Friday, 22'nd Apr 2022
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
10 Stocks That Have Moved Over 20% Since The Indices Plummeted
06:49pm, Friday, 08'th Apr 2022 Benzinga
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
The S&P fell by 14.
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
02:51pm, Friday, 08'th Apr 2022
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
04:10pm, Wednesday, 06'th Apr 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communication
These 2 Nasdaq Stocks Hit All-Time Highs Wednesday
06:12pm, Wednesday, 23'rd Mar 2022 The Motley Fool
Even in a tough market, one large-cap company and a small-cap rising star are beating the odds.
7 “A”-Rated Stocks to Ground Your Portfolio
01:40pm, Thursday, 17'th Mar 2022
It's a good time to make sure you have "A"-rated stocks in your portfolio. Many of the ones here have my triple-"A" rating.
Amphastar climbs after Q4 beat as Piper Sandler raises target to a Street high
04:41pm, Friday, 11'th Mar 2022 Seeking Alpha
The shares of the generic drugmaker, Amphastar Pharmaceuticals <>, have recorded the sharpest intraday gain in nearly two years on Friday as investors react to the…
Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript
03:00am, Friday, 11'th Mar 2022 The Motley Fool
AMPH earnings call for the period ending December 31, 2021.
Amphastar Pharmaceuticals (AMPH) Q4 2021 Earnings Call Transcript
03:00am, Friday, 11'th Mar 2022 The Motley Fool
AMPH earnings call for the period ending December 31, 2021.
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2021 Earnings Call Transcript
02:55am, Friday, 11'th Mar 2022 Seeking Alpha
Amphastar Pharmaceuticals (AMPH) Tops Q4 Earnings and Revenue Estimates
10:55pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Amphastar (AMPH) delivered earnings and revenue surprises of 10.53% and 8.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation
09:57pm, Thursday, 10'th Mar 2022 Seeking AlphaAmphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2021 Earnings Call Transcript
09:55pm, Thursday, 10'th Mar 2022
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2021 Earnings Call Transcript
Amphastar Pharmaceuticals Non-GAAP EPS of $0.42 beats by $0.05, revenue of $120.9M beats by $9.28M (NASDAQ:AMPH)
09:42pm, Thursday, 10'th Mar 2022 Seeking Alpha
Amphastar Pharmaceuticals press release (AMPH): Q4 Non-GAAP EPS of $0.42 beats by $0.05.Revenue of $120.9M (+26.0% Y/Y) beats by $9.28M.
Amphastar Pharmaceuticals (AMPH) Tops Q4 Earnings and Revenue Estimates
07:33pm, Thursday, 10'th Mar 2022
Amphastar (AMPH) delivered earnings and revenue surprises of 10.53% and 8.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
